CD8A and neoplasm: This effect seemed to be driven by PI3Kγ inhibition, as IPI-549 single treatment also demonstrated increased CD8+ T-cell infiltration into the tumor microenvironment (Figure 6B), an effect that was also observed in our previous study using PI3Kγ knock out mice.17